For those with diabetes, there is new hope for those suffering from diabetes and diabetes complications with Nrf2 activation.
Diabetes is the leading cause of end-stage renal disease (chronic kidney disease) and top diabetes organizations and Diabetes Research institutions like the American
READ MORE
LifeVantage Launches Protandim Nrf1
Publicly traded company, LifeVantage (LFVN), launched its patent-pending Protandim Nrf1 product by cyber-launch on May 17, 2016, at 6:00 PM Mountain Time, in Ogden, Utah.
Protandim Nrf1 is a companion product to the company's Protandim Nrf2 activator which has been shown
READ MORE
New Study: Nrf2 Signaling Normalizes Diabetic Tissue Regeneration
A new study on Nrf2 Signaling Normalizes Diabetic Tissue Regeneration was funded by the American Diabetes Association and published in March 2016.
Learn more about Nrf2 Activation by selecting the image below:
If you enjoyed this post please comment and share if you want more content like
READ MORE
Nrf2 And Diabetes: What Your Doctor Won’t Tell You
If you or someone you care for has diabetes, then you need to read this blog post, Nrf2 And Diabetes: What Your Doctor Won't Tell You.
There is a relatively new area of research that is changing the way researchers look at aging and age-related diseases. This is the study of Nrf2 activation and
READ MORE